Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial

BACKGROUND: TomoBreast is a unicenter, non-blinded randomized trial comparing conventional radiotherapy (CR) vs. hypofractionated Tomotherapy (TT) for post-operative treatment of breast cancer. The purpose of the trial is to compare whether TT can reduce heart and pulmonary toxicity. We evaluate ear...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Van Parijs, Hilde, Miedema, Geertje, Vinh-Hung, Vincent, Verbanck, Sylvia, Adriaenssens, Nele, Kerkhove, Dirk, Reynders, Truus, Schuermans, Daniel, Leysen, Katrien, Hanon, Shane, Van Camp, Guy, Vincken, Walter, Storme, Guy, Verellen, Dirk, De Ridder, Mark
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2012
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3432009/
https://ncbi.nlm.nih.gov/pubmed/22656865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-7-80
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller